2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations
- PMID: 19812802
- PMCID: PMC2782500
- DOI: 10.1016/s0828-282x(09)70715-9
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations
Abstract
The present article represents the 2009 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.
Le présent article contient la mise à jour 2009 des lignes directrices de la Société canadienne de cardiologie pour le diagnostic et le traitement de la dyslipidémie et pour la prévention des maladies cardiovasculaires chez l’adulte.
References
-
- Heart and Stroke Foundation of Canada The Growing Burden of Heart Disease and Stroke in Canada 2003. <http://www.cvdinfobase.ca/cvdbook/En/Index.htm> (Version current at August 13, 2009).
-
- Statistics Canada CANSIM<http://cansim2.statcan.ca> (Version current at August 13, 2009).
-
- Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326–33. - PubMed
-
- Ridker PM, Danielson E, Fonseca FA, et al. JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–207. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical